Evidence map›Paper›PMID 34620647›Full record

SynthesisClinical journal of the American Society of Nephrology : CJASN2021

Strategies to Prevent Acute Kidney Injury after Pediatric Cardiac Surgery: A Network Meta-Analysis.

Jef Van den Eynde, Nicolas Cloet, Robin Van Lerberghe, Michel Pompeu B O Sá, Dirk Vlasselaers, Jaan Toelen, Jan Y Verbakel, Werner Budts, Marc Gewillig, Shelby Kutty and 2 more

Open access · bronzeAbstract readSystematic ReviewNetwork Meta-Analysis
In one paragraph

Synthesis in Clinical journal of the American Society of Nephrology : CJASN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Kidney Injury Following Cardiac Surgery: A Review of Our Current Understanding.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2025
    Review
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Jef Van den EyndeHelen B. Taussig Heart Center, The Johns Hopkins Hospital and School of Medicine, Baltimore, Maryland.ORCID 0000-0002-5606-376
Nicolas CloetDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Robin Van LerbergheDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Michel Pompeu B O SáDivision of Cardiovascular Surgery of Pronto Socorro Cardiológico de Pernambuco-PROCAPE, University of Pernambuco-UPE, Recife, Brazil.ORCID 0000-0001-5356-2996
Dirk VlasselaersDepartment of Intensive Care Medicine, University Hospitals Leuven, Leuven, Belgium.
Jaan ToelenDivision of Woman and Child, Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
Jan Y VerbakelDepartment of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Werner BudtsDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Marc GewilligDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Shelby KuttyHelen B. Taussig Heart Center, The Johns Hopkins Hospital and School of Medicine, Baltimore, Maryland.
Hans PottelDepartment of Public Health and Primary Care, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
Djalila MekahliDepartment of Pediatric Nephrology, University Hospitals of Leuven, Leuven, Belgium.
KU Leuven · BEJohns Hopkins University · USUniversidade de Pernambuco · BRUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesAKI is a common complication after pediatric cardiac surgery and has been associated with higher morbidity and mortality. We aimed to compare the efficacy of available pharmacologic and nonpharmacologic strategies to prevent AKI after pediatric cardiac surgery. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: PubMed/MEDLINE, Embase, Cochrane Controlled Trials Register, and reference lists of relevant articles were searched for randomized controlled trials from inception until August 2020. Random effects traditional pairwise, Bayesian network meta-analyses, and trial sequential analyses were performed.

resultsTwenty randomized controlled trials including 2339 patients and 11 preventive strategies met the eligibility criteria. No overall significant differences were observed compared with control for corticosteroids, fenoldopam, hydroxyethyl starch, or remote ischemic preconditioning in traditional pairwise meta-analysis. In contrast, trial sequential analysis suggested a 80% relative risk reduction with dexmedetomidine and evidence of <57% relative risk reduction with remote ischemic preconditioning. Nonetheless, the network meta-analysis was unable to demonstrate any significant differences among the examined treatments, including also acetaminophen, aminophylline, levosimendan, milrinone, and normothermic cardiopulmonary bypass. Surface under the cumulative ranking curve probabilities showed that milrinone (76%) was most likely to result in the lowest risk of AKI, followed by dexmedetomidine (70%), levosimendan (70%), aminophylline (59%), normothermic cardiopulmonary bypass (57%), and remote ischemic preconditioning (55%), although all showing important overlap.

conclusionsCurrent evidence from randomized controlled trials does not support the efficacy of most strategies to prevent AKI in the pediatric population, apart from limited evidence for dexmedetomidine and remote ischemic preconditioning.

Indexed as

Ischemic PreconditioningAcute Kidney InjuryAdrenergic alpha-2 Receptor AgonistsAge FactorsBayes TheoremCardiac Surgical ProceduresCardiopulmonary BypassChild, PreschoolDexmedetomidineFemaleHumansInfantInfant, NewbornMaleRandomized Controlled Trials as TopicRisk AssessmentAdrenergic alpha-2 Receptor AgonistsDexmedetomidineacute kidney injuryacute renal failurecardiac surgical procedureschildrencongenital heart diseaseheartnetwork meta-analysisspecialtiessurgical

Identifiers

PMID34620647
PMCPMC8498996
OpenAlexW3204853261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.